General Information
Full Title: Better information, better decisions for your access strategy – Inmediata powered by SmartPHLEX a new platform
Date: June 16, 2022
Time: 02:30 PM CET
Duration: 1 hour(s)
Key Learnings
INMEDIATA is aimed at anybody interested in advance information on potential changes in the pharmaceutical market in order to formulate forward-looking strategies. To learn about the information collected in the new platform (INMEDIATA) and how to use it to generate trend analysis of future drug approvals as well as drugs undergoing P&R procedures in Spain.
Using INMEDIATA helps to:
- Early identification of changes in a specific therapeutic market due to the entry of new drugs.
- Characterize potential changes in a specific therapeutic area.
- Plan in advance and conduct specific studies in the therapeutic area of interest.
- Perform trend analysis in the Spanish P&R field